# Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy

Study · id `cardio:ct-nct01838850` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01838850](<https://clinicaltrials.gov/study/NCT01838850>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01838850

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 344 participants.

## Technical summary

Registry record NCT01838850. Randomized; quadruple masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2014-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 344 participants (enrolled count; ClinicalTrials.gov record NCT01838850, source copy `cardio:ctgov-nct01838850-2018-12-24`, retrieved 2026-10-26)
- Start date: 2013-04 (registry gives no type) (ClinicalTrials.gov record NCT01838850, source copy `cardio:ctgov-nct01838850-2018-12-24`, retrieved 2026-10-26)
- Primary completion: 2014-08 (actual) (ClinicalTrials.gov record NCT01838850, source copy `cardio:ctgov-nct01838850-2018-12-24`, retrieved 2026-10-26)
- Completion: 2014-08 (actual) (ClinicalTrials.gov record NCT01838850, source copy `cardio:ctgov-nct01838850-2018-12-24`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01838850, source copy `cardio:ctgov-nct01838850-2018-12-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01838850-2018-12-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy
- Condition: Essential Hypertension
- Intervention (Drug): CS8635 20/5/12.5mg and placebo
- Intervention (Drug): Olmetec® Plus 20/12.5mg and placebo
- Lead sponsor: Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial (`cardio:pubmed-26691333`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4f96aac04c2a214bbac5a86fa1585711ace232012bb56b9160c8bbc1f8f8b71c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
